Eccles Health Sciences Library
 
201 - 225 of 274
Number of results to display per page
TitleDateTypeSetname
201 The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis2021-09Textehsl_novel_jno
202 Sixth Nerve Palsy and Myocarditis as the Only Presenting Manifestation of Giant Cell Arteritis2021-09Textehsl_novel_jno
203 Vision Loss From Giant Cell Arteritis in Patients With Other Ocular Diagnoses2021-06Textehsl_novel_jno
204 Granuloma Annulare, Scalp Necrosis, and Ischemic Optic Neuropathy From Giant Cell Arteritis After Varicella-Zoster Virus Vaccination2021-06Textehsl_novel_jno
205 Giant Cell Arteritis Presenting as Bilateral Optic Perineuritis in an African Man2021-06Textehsl_novel_jno
206 Paracentral Acute Middle Maculopathy as the Initial Presentation of Giant Cell Arteritis2021-06Textehsl_novel_jno
207 Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis2021-06Textehsl_novel_jno
208 Bilateral Scalp Necrosis in Giant Cell Arteritis2021-03Textehsl_novel_jno
209 Neurosarcoidosis Masquerading as Giant Cell Arteritis With Incidental Meningioma2021-03Textehsl_novel_jno
210 Perineural Optic Nerve Enhancement in Giant Cell Arteritis: A Case Report and Review of the Literature2021-03Textehsl_novel_jno
211 Magnetic Resonance Imaging Abnormalities of the Optic Nerve Sheath and Intracranial Internal Carotid Artery in Giant Cell Arteritis2021-03Textehsl_novel_jno
212 Temporal Artery Biopsy in the Workup of Giant Cell Arteritis: Diagnostic Considerations in a Veterans Administration Cohort2020-12Textehsl_novel_jno
213 Arteritic Orbital Ischemia Producing Afferent and Efferent Pupillary Defects2020-12Textehsl_novel_jno
214 Considerations for the Treatment of Inflammatory Neuro-Ophthalmologic Disorders During the COVID-19 Pandemic2020-09Textehsl_novel_jno
215 Internuclear Ophthalmoplegia as the Presenting Sign of Giant Cell Arteritis2020-03Textehsl_novel_jno
216 Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?2020-03Textehsl_novel_jno
217 Internuclear Ophthalmoplegia as the Presenting Sign of Giant Cell Arteritis2020-03Textehsl_novel_jno
218 Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?2020-03Textehsl_novel_jno
219 Diplopia and Giant Cell Arteritis2019-12Textehsl_novel_jno
220 Embouchure Claudication A Trumpeters Unique Presentation of Giant Cell Arteritis2019-12Textehsl_novel_jno
221 Should Antiviral/Anti-Varicella Zoster Virus Treatment Be Used in Patients With Giant Cell Arteritis?2019-03Textehsl_novel_jno
222 Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes2019-03Textehsl_novel_jno
223 IL-6 Blockade and its Therapeutic Success in Giant Cell Arteritis2018-12Textehsl_novel_jno
224 Anti-Interleukin-6 Antibody as Treatment for Giant Cell Arteritis2018-12Textehsl_novel_jno
225 Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis2018-03Textehsl_novel_jno
201 - 225 of 274